HLA-DRA and hyperlipidemia: Furthermore, based on the results of Phe‐MR analysis (Figure S3), it is suggested that lower expression of HLA‐DRA may contribute to a decreased risk of certain other disorders, including hematuria, chronic sinusitis, hyperlipidaemia, and inflammatory spondyloarthropathy.